Clinical Trials · NCT05897372
Feasibility of Aggressive Albuminuria Reduction in Biopsy-Proven Diabetic Nephropathy - a Pilot Study
- Phase
- Phase 2
- Recruitment status
- Terminated
- Sponsor
- Iain Bressendorff
- Enrollment
- 1
- Start date
- Aug 2023
- Locations
- 1 site, Denmark
- Primary endpoint
- urine albumin/creatinin-ratio (UACR) reduction to less than 50% of baseline